Poor
Not Aligned
Patient Risk:
High
Summary
Only a small subset of the extracted claims aligns with the provided label content (notably the Schedule II status and some abuse/cardiovascular/seizure warnings). Most claims are unrelated to FDA-approved prescribing information (e.g., street pricing, insurance co-pays, counterfeit-specific details, legal penalty specifics, and several side effects stated as 'common' without label support), and many safety assertions are unsupported or not verifiable from the supplied label excerpts.
Category Scores
Accurate Statements
In the United States, Adderall is a Schedule II controlled substance.
Supported: DRUG ABUSE AND DEPENDENCE -> Controlled Substance
Schedule II controlled substances have a high potential for abuse and dependence.
Partially supported by label language about high potential for abuse/misuse/addiction in DRUG ABUSE AND DEPENDENCE and Controlled Substance section.
Long-term Adderall use can lead to dependence and addiction.
Partially supported by DRUG ABUSE AND DEPENDENCE -> Abuse, Misuse, and Addiction
Common side effects of Adderall include increased heart rate.
Partially supported: WARNINGS -> Increased Blood Pressure and Heart Rate
More serious side effects can include high blood pressure.
Partially supported: WARNINGS -> Increased Blood Pressure and Heart Rate
More serious side effects can include rapid or irregular heartbeat.
Partially supported: WARNINGS -> Increased Blood Pressure and Heart Rate
More serious side effects can include seizures.
Partially supported: WARNINGS -> Seizures
Unsupported Statements
The street price of 30 mg Adderall can vary significantly based on location, availability, and the seller.
Absent from the supplied label content.
Generally, prices can range from $20 to $30 or more per 30 mg tablet.
Absent from the supplied label content.
Street price of Adderall can be influenced by whether the formulation is immediate-release versus extended-release.
Absent from the supplied label content.
Street price of Adderall can be influenced by whether the pills are counterfeit.
Absent from the supplied label content.
Adderall is commonly sold in pill form.
Absent from the supplied label content.
Dosages like 10 mg, 20 mg, and 30 mg are prevalent in street sales of Adderall.
Absent from the supplied label content.
Street transactions for Adderall may involve individual pills.
Absent from the supplied label content.
Larger quantities of Adderall might be purchased on the street at a reduced per-pill price.
Absent from the supplied label content.
Purchasing Adderall without a prescription carries significant risks.
Not clearly supported as a 'street purchase' claim; label focuses on abuse/misuse risks rather than counterfeit/illicit transaction mechanics.
Buying Adderall without a prescription can result in receiving counterfeit pills containing dangerous, unlisted substances.
Absent from the supplied label content.
Buying Adderall without a prescription can result in incorrect dosages of the active ingredients.
Absent from the supplied label content.
Possession of a controlled substance without a valid prescription carries legal repercussions.
Legal penalty statements are absent from the supplied label content.
Using Adderall without medical supervision can lead to anxiety.
Absent from the supplied label content.
Using Adderall without medical supervision can lead to addiction.
Label supports abuse/misuse/addiction risk broadly, but the specific framing ('without medical supervision' leading to addiction) is not directly supported as stated.
Using Adderall without medical supervision can lead to psychosis.
Label supports exacerbation of preexisting psychosis, but the claim is not supported as stated ('without medical supervision can lead to psychosis').
The street price of Adderall is often considerably higher than the cost of obtaining it through a legitimate prescription.
Absent from the supplied label content.
Insurance coverage can significantly reduce the out-of-pocket expense for patients with a prescription for Adderall.
Absent from the supplied label content.
Without insurance or when purchasing illicitly, the cost of Adderall can escalate.
Absent from the supplied label content.
A prescription for a month's supply might cost $30 to $100 with insurance.
Absent from the supplied label content.
Obtaining the same amount of Adderall on the street could cost several hundred dollars.
Absent from the supplied label content.
Legally prescribed alternatives for treating ADHD include other stimulant medications such as methylphenidate (e.g., Ritalin, Concerta).
Absent from the supplied label content.
Legally prescribed alternatives for treating ADHD include amphetamine salts such as Vyvanse and Dexedrine.
Absent from the supplied label content.
Non-stimulant medications for ADHD include atomoxetine (Strattera).
Absent from the supplied label content.
Non-stimulant medications for ADHD include guanfacine (Intuniv).
Absent from the supplied label content.
Non-stimulant medications for ADHD include clonidine (Kapvay).
Absent from the supplied label content.
Behavioral therapy and lifestyle adjustments are important components of ADHD management.
Absent from the supplied label content.
The prescription cost of Adderall varies widely depending on insurance coverage, pharmacy pricing, and the specific dosage and quantity prescribed.
Absent from the supplied label content.
Without insurance, a prescription for Adderall can range from approximately $150 to $300 or more for a 30-day supply.
Absent from the supplied label content.
With insurance, the co-pay for Adderall is typically much lower, often between $10 and $50.
Absent from the supplied label content.
Possessing Adderall without a valid prescription is illegal.
Legal-status statements are absent from the supplied label content.
Possession charges for Adderall can lead to fines, probation, and even jail time.
Absent from the supplied label content.
Penalties for Adderall possession vary based on the quantity possessed and the jurisdiction.
Absent from the supplied label content.
Common side effects of Adderall include decreased appetite.
Absent from the supplied label content (in provided excerpts).
Common side effects of Adderall include dry mouth.
Absent from the supplied label content (in provided excerpts).
Common side effects of Adderall include difficulty sleeping.
Absent from the supplied label content (in provided excerpts).
Common side effects of Adderall include headache.
Absent from the supplied label content (in provided excerpts).
Common side effects of Adderall include stomach pain.
Absent from the supplied label content (in provided excerpts).
More serious side effects of Adderall can include severe anxiety.
Absent from the supplied label content (in provided excerpts).
More serious side effects of Adderall can include mood changes.
Absent from the supplied label content (in provided excerpts).
More serious side effects of Adderall can include hallucinations.
Absent from the supplied label content (in provided excerpts).
DrugPatentWatch.com provides data on drug patents, exclusivity periods, and generic entry timelines.
Absent from the supplied label content.
Drug patent status and exclusivity/generic entry timelines can influence the overall cost and availability of medications.
Absent from the supplied label content.
Contradictions
Important Omissions
Boxed warnings language and key label-specific safety/abuse monitoring/disposal/storage instructions are not represented in the extracted claims set.
Importance:
Moderate
Contraindications (hypersensitivity; MAOI use/within 14 days) are not addressed in the extracted claims set.
Importance:
Moderate
Labeled guidance for patients with serious cardiac disease (avoid in structural cardiac abnormalities/cardiomyopathy/serious arrhythmia/CAD) is not reflected in the extracted claims set.
Importance:
Moderate
Labeled psychiatric warning specificity (exacerbation of preexisting psychosis) is not accurately captured by the extracted 'psychosis' claim.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
High
The extracted set includes many unsupported or non-label claims (especially counterfeit/illicit purchase details and numerous side effects labeled as 'common' without label support), which could mislead readers about Adderall’s labeled safety profile and risks. Only limited portions align with provided label excerpts.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Predominantly non-label market/legal/counterfeit and multiple adverse-effect claims are absent or unsupported by the provided FDA prescribing information excerpts.
Suggested Improvement
Restrict claims to text supported by the supplied Adderall label sections (e.g., controlled substance status, abuse/misuse/addiction warnings, cardiac disease precautions, BP/HR monitoring, seizure warning, and contraindications). Remove or clearly separate non-label economic/legal/counterfeit details and avoid stating adverse effects as 'common' unless supported by the label.